San Francisco, California
London, United Kingdom
Personalized medicine is what inspired Marcia Fournier to start her own company, BIOARRAY Therapeutics Inc. (BIOARRAY) a start-up biotech based in CT. BIOARRAY is developing diagnostic tests to match a breast cancer patient with the right drug the first time. BIOARRAY’s lead test has been shown to reduce ineffective treatments by over 50% in proof of concept studies. Marcia will talk about how the company is developing the technology from discovery to product development stage leveraging the study of cancer in reverse, and the experience of partners.
BIOARRAY is a recipient of Avon Foundation for Women and Connecticut Innovations funds. BIOARRAY was nominated the “Most Promising Life Science Product” by CT Technology Council and is a MassChallenge Accelerator Winner.
Marcia, a molecular biologist, came to the United States from Brazil about 15 years ago. Marcia is trained in genetics with 10+ years of experience in cancer research. She most recently held a position at GlaxoSmithKline, Oncology Center of Excellence for Drug Discovery. Marcia’s work as a doctoral fellow at the Dana-Farber Institute and postdoctoral fellow at UC Berkeley led to seminal publications on biomarker discovery.
Note: This event requires pre-registration. No at door sales will be available.
Attendees will need to check in at the visitor center, get a badge, then drive to the the onsite parking lot and walk across the street to Building 220.
When & Where
CURE is the bioscience cluster of Connecticut, a diverse network of small and large life and health care sciences companies, universities, scientists, educators, students, entrepreneurs, mentors, business experts, and investors. Together we cultivate entrepreneurship, build bioscience companies, and collaborate to ensure a sustainable, high-value bioscience and healthcare community that improves our quality of life and keeps the Connecticut economy strong.